St. Jude Medical Announces FDA Approval of FlexAbility Ablation Catheter

St. Jude Medical, Inc.

, a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of the FlexAbility™ Ablation Catheter, a new ablation technology used by electrophysiologists for the treatment of cardiac arrhythmias. Designed with feedback from leaders in the electrophysiology community, the FlexAbility catheter combines a bendable irrigated catheter tip with an advanced handle and next generation shaft design. The unique flexible tip was developed to conform better to the cardiac anatomy, allowing for effective lesion formation. This added flexibility, in addition to the catheter's ability to maneuver easily and reliably in challenging cases, was designed to enhance the quality of care for patients around the world who require ablation procedures.